Key result
Elevated serum sulfatide levels are linked to increased risk of restenosis after PCI.
Why the study?
The mechanisms underlying restenosis after PCI are complex and not completely understood, motivating investigation of serum sulfatide's role.
Does high serum concentration of sulfatide predict restenosis in patients with stable atherosclerotic coronary artery disease after percutaneous coronary intervention?
Cohort (n=68)
No
Does high serum concentration of sulfatide predict restenosis in patients with stable atherosclerotic coronary artery disease after percutaneous coronary intervention?
High serum concentration of sulfatide may serve as a risk factor for restenosis following percutaneous coronary intervention in patients with stable coronary artery disease.
Answers are grounded in this paper and cite their sources.
Sulfatide levels should not guide post-PCI decisions; hypothesis-generating for restenosis prediction in stable CAD.
Objective: Restenosis after Percutaneous Coronary Intervention (PCI) is regarded as the result of a combination of various pathological events. The mechanisms are complex and not completely understood. This study aims to determine the correlation between the concentration of serum sulfatide and restenosis after PCI. Method: We studied 68 consecutive patients with CHD of single-vessel disease who successfully underwent PCI. All patients were evaluated by a follow-up angiography approximately 6.5 months after the PCI and were divided into two groups, the restenosis (20 patients) and the nonrestenosis (48 patients). We measured and compared serum sulfatide levels and conventional cardiovascular risk factors in those two groups. Result: The serum sulfatide concentration (18.73 ± 3.81 μmol/L) in the restenosis group was significantly higher than that (11.52 ± 3.37 μmol/L) in the nonrestenosis group (p<0.01). Multiple logistic regression analysis for risk factors revealed a significant correlation between serum sulfatide and restenosis after PCI (p<0.05). The concentration of serum sulfatide was positively correlated with the coronary percent stenosis at the time of follow-up angiography (r=0.32, p<0.05). Conclusion: High concentration of serum sulfatide is therefore a risk factor for restenosis after PCI in patients with CHD.
No takes yet. Share an insight, caveat, or question.
Ran Li (2015) conducted a cohort in Stable atherosclerotic coronary artery disease (n=68). Serum sulfatide concentration vs. Lower serum sulfatide concentration was evaluated on Mean serum sulfatide concentration in patients with vs. without restenosis (μmol/L) (p=<0.001). High serum concentration of sulfatide was associated with a higher risk of restenosis after percutaneous coronary intervention, with higher mean levels observed in patients with restenosis compared to those without.
Synapse has enriched 10 related papers. Consider them for comparative context: